31 The Procter & Gamble Company and Subsidiaries Consolidated Statement of Cash Flows Years Ended June 30 2000 $2,294 3,542 2,191 463 64 (176) (883) (404) (122) 4,675 (3,018) 419 (2,967) 221 (5,345) (1,796) 243 4,196 (1,409) 336 (1,766) (196) (13) (879) $1,415 2001 $1,415 2,922 2,271 (102) (122) (67) 801 57 44 5,804 (2,486) 788 (138) (7) (1,843) (1,943) (1,092) 1,356 (226) 141 (1,250) (3,014) (56) 891 $2,306 2002  $2,306 4,352 1,693 389 96 159 684 (98) 467 7,742 (1,679) 227 (5,471) 88 (6,835) (2,095) 1,394 1,690 (461) 237 (568) 197 17 1,121  $3,427 Cash and Cash Equivalents, Beginning of Year Operating Activities Net earnings Depreciation and amortization Deferred income taxes Change in accounts receivable Change in inventories Change in accounts payable, accrued and other liabilities Change in other operating assets and liabilities Other Total Operating Activities Investing Activities Capital expenditures Proceeds from asset sales Acquisitions Change in investment securities Total Investing Activities Financing Activities Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Proceeds from the exercise of stock options Treasury purchases Total Financing Activities Effect of Exchange Rate Changes on Cash and Cash Equivalents Change in Cash and Cash Equivalents Cash and Cash Equivalents, End of Year Amounts in millions $700 1,712  – 236 $735 1,701  –  108 $629 941 150 571 Supplemental Disclosure Cash payments for: Interest Income taxes Non-cash spin-off of Jif and Crisco Liabilities assumed in acquisitions  See accompanying Notes to Consolidated Financial Statements